Scientists revealed the effectiveness of vaccination against the risk of death from coronavirus in the elderly. According to the results of the study of the French Research Group EPI-PHARE, COVID-19 vaccination reduces the risk of hospitalization and fatal outcome among people over 50 years old by 90 percent. It is reported by RIA Novosti.
It is reported that according to FranceInfo, scientists as part of the study compared the health data of 11 million people of this age group vaccinated from coronavirus, with data 11 million of their peers who were not vaccinated. It is noted that the first group includes patients vaccinated Pfizer / Biontech, Moderna and Astrazeneca.
According to the study, from 14 days after the introduction of the second dose of the vaccine vaccine, the risk of hospitalization decreased by more than 90%. Also, scientists have established that vaccination is also effective against the “Delta” of the Coronavirus.
In the period of studying the action of vaccinations against the “Delta” -Stamma, its effectiveness was 84% in the group of persons over 75 years and 92% among people aged 50 to 75 years.
Earlier, the Russian direct investment fund (RDII) said that the Russian single-component drug from Coronavirus Satellite Light turned out to be effective than 80 percent among the elderly in Argentina. According to a study published in EclinicalMedicine journal, the drug has shown efficiency from 78.6 to 83.7 percent among citizens aged 60 to 79 years.
In April, the Russian doctor and TV host Alexander Butchestnikov spoke about the testimony for vaccination from COVID-19. According to him, the vaccination is obligatory for those who suffer from chronic diseases, as well as people from 65 years. The doctor stated that they first need such protection.
.